![]()
TURKU, FI / ACCESS Newswire / June 17, 2026 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN)
Faron Pharmaceuticals Ltd | Company announcement | June 17, 2026 at 09:00:00 EEST
Standard form for notification of major holdings
|
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FIN-FSA) |
|||||
|
1. Identity of the issuer: |
|||||
|
2. Reason for the notification (please tick the appropriate box or boxes): |
|||||
|
3. Details of person subject to the notification obligation: |
|||||
|
Name: |
City and country of residence: |
||||
|
4. Full name of shareholder(s) (if different from 3.): |
|||||
|
5. Date on which the threshold was crossed or reached: |
|||||
|
6. Total positions of person(s) subject to the notification obligation: |
|||||
|
% of shares and voting rights |
% of shares and voting rights through financial instruments |
Total of both in % (7.A + 7.B) |
Total number of shares and voting rights of issuer |
||
|
Resulting situation on the date on which threshold was crossed or reached |
0.12 |
9.99 |
10.11 |
206,411,888 |
|
|
Position of previous notification (if applicable) |
0.13 |
10.07 |
10.20 |
||
|
7. Notified details of the resulting situation on the date on which the threshold was crossed or reached: |
|||||||||
|
A: Shares and voting rights |
|||||||||
|
Class/type of |
Number of shares and voting rights |
% of shares and voting rights |
|||||||
|
Direct |
Indirect |
Direct |
Indirect |
||||||
|
FI4000153309 |
0 |
246,335 |
0 |
0.12 |
|||||
|
– |
– |
– |
– |
– |
|||||
|
– |
– |
– |
– |
– |
|||||
|
SUBTOTAL A |
246,335 |
0.12 |
|||||||
|
B: Financial Instruments according to SMA 9:6a |
|||||||||
|
Type of financial instrument |
Expiration |
Exercise/ |
Physical or cash settlement |
Number of shares and voting rights |
% of shares and voting rights |
||||
|
Rights of Use |
n/a |
n/a |
n/a |
20,374,993 |
9.87 |
||||
|
Swaps |
15/10/2027 |
n/a |
Cash |
245,294 |
0.12 |
||||
|
– |
– |
– |
– |
– |
– |
||||
|
SUBTOTAL B |
20,620,287 |
9.99 |
|||||||
|
8. Information in relation to the person subject to the notification obligation (please tick the applicable box): |
|||
|
Name |
% of shares and voting rights |
% of shares and voting rights through financial instruments |
Total of both |
|
– |
– |
– |
– |
|
– |
– |
– |
– |
|
– |
– |
– |
– |
|
– |
– |
– |
– |
|
– |
– |
– |
– |
|
9. In case of proxy voting: [name of the proxy holder] will cease to hold [% and number] voting rights as of Click here to enter a date. |
|||
|
10. Additional information: |
|||
Done at London, United Kingdom on 15.6.2026.
SOURCE: Faron Pharmaceuticals
View the original press release on ACCESS Newswire
Media gallery
